Rare diseases
Investigational molecules
Locations
A plain-language summary of the goals, design and what participants do
This study focuses on the prevention of Sexually Transmitted Infections, which are infections passed from one person to another through sexual contact. Specifically, the research looks at Neisseria gonorrhoeae, which causes gonorrhea, Chlamydia trachomatis, which causes chlamydia, and Treponema pallidum, the bacteria that causes syphilis. The study involves individuals who are already using PrEP, a medication taken to prevent HIV infection.
The purpose of the study is to compare two different ways of using doxycycline to prevent these infections after potential exposure. One method involves taking the medication every week, while the other method involves taking the medication only after specific events occur. Participants will be assigned to one of these two groups to see which schedule is more effective at reducing the number of new infections.
The trial runs in 2 steps – from screening to follow-up. Each step says what happens and what the team monitors.
7 criteria
3 criteria
Tell us about your condition – we search every trial in Europe and connect you with the right site.
We usually reply within a few days
Where you can join this trial
Countries are shaded by recruitment status. Click a recruiting country to ask about joining there.
RecruitingJoining a clinical trial can seem overwhelming. We guide you step by step, so you know exactly what to expect and how we support you through the process.
Doxycycline is an antibiotic used in this study to prevent certain sexually transmitted infections after a potential exposure.
This is a bacterial infection that primarily affects the mucous membranes of the reproductive tract. It is commonly spread through sexual contact. The infection can cause inflammation and discharge in the genital area. In some cases, it may also affect the throat or rectum. If left unchecked, the infection can spread further into the reproductive organs.
This infection is caused by a specific type of bacteria that targets the reproductive system. It is typically transmitted through sexual activity. Many individuals do not show any obvious signs of the infection initially. As it progresses, it can cause irritation and discharge in the genital tract. The bacteria can also infect other parts of the body like the rectum or throat.
This is a bacterial infection that progresses through several distinct stages. It often begins with a small, painless sore at the site where the bacteria entered the body. Following this initial stage, the infection can move into a period where rashes appear on different parts of the body. If it continues to advance, the bacteria can spread to internal organs and tissues. The progression is typically slow and can affect various systems in the body over time.
Other trials in this disease – keep exploring while you decide
BelgiumBelgiumsourced from the EU Clinical Trials Register and site verification
Want to learn more about this trial or check if you can participate?
Tell us about your condition – we search every trial in Europe and connect you with the right site.
